About Us
About Carna
Management
Our Business
Products & Services
Products
Kinase Proteins and Other Protein Products
Assay Kits
Services
Activity-based Biochemical Screening/Profiling Assay Services
Cell-based Assay Services
Pricing & Technical Inquiry
Drug Discovery
Pipeline
Science
Technology
Partnering
Investors
News
Financial Reports/Presentations
Financial Highlights
IR Schedule
IR Contact
JP
EN
JP
EN
Kinase Inhibitor Discovery
with an untiring quest for future therapeutics
Our Business
Products & Services
Drug Discovery
Latest News
May 10, 2023
Investors
FY2023 Q1 Presentation
May 10, 2023
Investors
Consolidated Financial Results for the First Quarter of the Year Ending December 31, 2023
Mar 07, 2023
Investors
Corporate Presentation Feb. 2023
Mar 07, 2023
Investors
Carna Biosciences Regains Exclusive Development and Commercialization Rights to AS-1763 in Greater China
Feb 10, 2023
Investors
Corporate Presentation Feb. 2023
Feb 10, 2023
Investors
FY2022 Presentation
Feb 10, 2023
Investors
Consolidated Financial Results for the Year Ended December 31, 2022
Jan 25, 2023
Investors
Carna Initiates Dosing in the MAD Part of Phase 1 Trial of AS-0871
About Us
Investors
Investor Contact
Products & Services Contact